Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis

Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis

Comorbidity influences screening practice, treatment choice, quality of life, and survival. The presence of comorbidities and medication use could place patients at greater risks of adverse effects from certain interventions. We conducted a longitudinal cohort study in the General Practice Research...

Full description

Bibliographic Details
Main Authors:	Haojie Li, Elizabeth Hodgson, Louise Watson, Amit Shukla, Jeanenne J. Nelson
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Journal of Cancer Epidemiology
Online Access:	http://dx.doi.org/10.1155/2012/291704

Similar Items

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
by: Amit M. Algotar PhD, MBBS, et al.
Published: (2011-05-01)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
by: Nigel P. Murray, et al.
Published: (2014-01-01)

PSA testing for men at average risk of prostate cancer
by: Bruce K Armstrong, et al.
Published: (2017-07-01)

Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer
by: Sushant V Chavan, et al.
Published: (2014-01-01)

The evaluation of outcome, benefit, medical resources consumption to elder men screened prostate cancer with DRE and PSA
by: Chien-Yu Su, et al.
Published: (2009)

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men
by: Wu ZY, et al.
Published: (2019-08-01)

Performance of PSA and of PSA density in the diagnosis of prostate carcinoma
by: Antonio Carlos Pereira Martins, et al.
Published: (2002-01-01)

Serum PSA in the Diagnosis of Prostate Cancer in Thai men : A Preliminary Report
by: Pikul Laisupasin, et al.
Published: (2015-02-01)

Serum gonadotropins, cortisol, PSA, and micronutrient levels among men with prostate carcinoma
by: Wasiu Eniola Olooto, et al.
Published: (2021-07-01)

Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
by: Price D, et al.
Published: (2011-04-01)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
by: Jin-Woo Jung, et al.
Published: (2019-01-01)

Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1
by: Lincoln GL Tan, et al.
Published: (2017-01-01)

PSA screening for prostate cancer
by: Marcus V. Sadi

Prostate Specific Antigen (PSA)
by: Joan H. How Anitz
Published: (1993-01-01)

Molecular strategies to reduce unnecessary repeat prostate biopsies of men with elevated serum PSA
by: Pang, Karl H.
Published: (2018)

High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort.
by: Alan T Clarke, et al.
Published: (2016-01-01)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
by: Ulrika Rönningås, et al.
Published: (2019-07-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

PSA in early diagnosis of prostate cancer
by: Jabal Ameli P, et al.
Published: (1995-07-01)

Prostate cancer screening with PSA: "Aequanimitas"
by: Marcus V. Sadi Dr.
Published: (2013-07-01)

Experiences of Uncertainty in Men With an Elevated PSA
by: Caitlin Biddle MA, et al.
Published: (2017-01-01)

Comparison of the Clinical Value of Complexed PSA and Total PSA in the Discrimination between Benign Prostatic Hyperplasia and Prostate Cancer
by: Fröhner, Michael, et al.
Published: (2014)

Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination
by: Ari Miotto Jr, et al.
Published: (2004-04-01)

Identification of metabolic pathways influenced by the G-protein coupled receptors GprB and GprD in Aspergillus nidulans.
by: Wagner R de Souza, et al.
Published: (2013-01-01)

Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml
by: Niraj Kumar, et al.
Published: (2019-01-01)

Iowa men's decision-making process for prostate cancer prevention via screening with the prostate-specific antigen (PSA) test
by: Gregory, Daniel J
Published: (2007)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
by: Strittmatter F, et al.
Published: (2011-10-01)

Clinical characteristics and comorbidities of psoriatic arthritis (PsA) in Hong Kong
by: Lai Tin Lok, et al.
Published: (2018-12-01)

Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1
by: Cheng Wang, et al.
Published: (2021-01-01)

Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL?
by: W. F. S. Busato, et al.
Published: (2015-04-01)

Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
by: Ellen Wright, et al.
Published: (2012-01-01)

An investigation of the utilisation and safety of influenza A(H1N1)pdm 2009 vaccines using the UK GPRD
by: Sammon, Cormac James
Published: (2013)

Prostate Specific Antigen (PSA): The Historical Perspective
by: T. Ming Chu
Published: (2020-12-01)

Histomorphologic Correlation of PSA Levels in Prostatic Pathology
by: Deepak Panasseril Jayapradeep, et al.
Published: (2017-10-01)

Analysis of Prostate Specific Antigen (PSA) level on Medical Check-up (MCU) Participants
by: Linda Rosita, et al.
Published: (2019-01-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
by: Murat Zor, et al.
Published: (2018-12-01)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01)

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
by: Emerson P. Gregorio, et al.
Published: (2007-04-01)

Malakoplakia of the prostate diagnosed by elevated PSA level and transrectal prostate biopsy
by: Sacit Nuri Görgel, et al.
Published: (2011-04-01)

Cannot write session to /tmp/vufind_sessions/sess_pe1qvcvfgrnc48blvuhjua582r